Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-14

Clinical Trial Update: Inhaled Milrinone in Cardiac Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled milrinone in patients undergoing cardiac surgery for pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milrinone (inhaled) (milrinone inhalation)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED